REATA PHARMACEUTICALS V. CONTROLLER: Clarifying Patentability And Evidentiary Standards Reata Pharmaceuticals Inc. vs Deputy Controller…
SJP TeamJuly 7, 2025
Recent Comments
No comments to show.
Recent Posts
Recent Comments
Archives
- September 2025
- August 2025
- July 2025
- June 2025
- May 2025
- April 2025
- March 2025
- February 2025
- January 2025
- November 2024
- October 2024
- September 2024
- August 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- February 2024
- January 2024
- November 2023
- July 2023
- June 2023
- May 2023
- September 2022
- August 2022
- June 2022
- May 2022
- April 2022
- April 2021
- February 2021
- December 2020
- August 2020
- June 2020
- January 2020
- December 2019
- November 2019
- September 2019
- August 2019
- September 2018
- August 2018
- April 2018
- February 2018
- January 2018
- July 2017
- June 2017
- February 2017
- November 2016
- June 2016
- May 2016
- February 2016
- January 2016
- November 2015
- September 2015
- July 2015
- June 2015
Tags
affidavit
Albemarle
ASSIGNMENT
Biosimilar
Bolar Exemption
CALCUTTA HIGH COURT
Convention filing
Copyright
DABUS
DelhiHighCourt
Design
DIVISIONAL APPLICATION
Dolby
Dong Yang
first to use
FORM1
Form24
GEOGRAPHICAL INDICATIONS
GLOBAL FTO
Indian Patent office
INFRINGEMENT
INFRINGEMENT RISK
Intellectual Property
INVENTORSHIP
IP
IPR
LAVA
NEC
Newgen
novartis case
Patent
PatentLaw
PCT Filing
REATA PHARMACEUTICALS
Review petition
section 3(d)
Section 77
Shindengen
Star
STRATJURIS
symbiosis
Trademark
Trade secrets
WTR1000
Zydus
About the blog
Lorem ipsum dolor sit amet, consectetur elit porta. Vestibulum ante justo, volutpat quis porta non, vulputate id diam. Lorem et ipsum dolor sit amet, consectetur adipiscing elit. Morbi vitae sem in massa sagittis.
Recent Posts
- (no title) September 2, 2025
- STRATJURIS NEWSLETTER AUGUST- 2025 August 4, 2025
- Family Legacy and Intellectual Property July 18, 2025
- STRATJURIS NEWSLETTER JULY- 2025 July 7, 2025
- STRATJURIS NEWSLETTER JUNE- 2025 June 5, 2025
Tags
affidavit
Albemarle
ASSIGNMENT
Biosimilar
Bolar Exemption
CALCUTTA HIGH COURT
Convention filing
Copyright
DABUS
DelhiHighCourt
Design
DIVISIONAL APPLICATION
Dolby
Dong Yang
first to use
FORM1
Form24
GEOGRAPHICAL INDICATIONS
GLOBAL FTO
Indian Patent office
INFRINGEMENT
INFRINGEMENT RISK
Intellectual Property
INVENTORSHIP
IP
IPR
LAVA
NEC
Newgen
novartis case
Patent
PatentLaw
PCT Filing
REATA PHARMACEUTICALS
Review petition
section 3(d)
Section 77
Shindengen
Star
STRATJURIS
symbiosis
Trademark
Trade secrets
WTR1000
Zydus
About Salient
Lorem ipsum dolor sit amet, consectetur elit porta. Vestibulum ante justo, volutpat quis porta non, vulputate id diam. Lorem et ipsum dolor sit amet, consectetur adipiscing elit. Morbi vitae sem in massa sagittis.